Relationship between glycopeptide use and decreased susceptibility to teicoplanin in isolates of coagulase-negative staphylococci

被引：13

作者：

Bertin, M

Muller, A

Bertrand, X

Cornette, C

Thouverez, M

Talon, D ^{[1
]}

机构：

[1] CHU Jean Minjoz, Serv Hyg Hosp & Epidemiol Mol, F-25030 Besancon, France

[2] CHU Besancon, Pharm Cent, F-25030 Besancon, France

来源：

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 2004年 / 23卷 / 05期

关键词：

D O I：

10.1007/s10096-004-1129-1

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

To investigate the relationship between glycopeptide use and decreased susceptibility to teicoplanin in coagulase-negative staphylococci (CNS) isolates, data on teicoplanin susceptibility and glycopeptide use from existing microbiology laboratory and pharmacy databases were collected for the period between July 2000 and March 2001. Pooled data for the entire study period were first used to analyse associations. Univariate analysis showed that the incidence of CNS with decreased susceptibility to teicoplanin was significantly correlated with the use of glycopetides, particularly with vancomycin use. This association was confirmed by multivariate analysis. This study suggests that variations in antimicrobial resistance are related to variations in antimicrobial use in the model of CNS with decreased susceptibility to teicoplanin, thus confirming the usefulness of restricting antimicrobial prescribing as a means of controlling resistance.

引用

收藏

页码：375 / 379

页数：5

相关论文

共 29 条

[1] ANTIMICROBIAL SUSCEPTIBILITY OF COAGULASE-NEGATIVE STAPHYLOCOCCI [J].

ARCHER, GL ;

CLIMO, MW .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (10) :2231-2237

[2]

ARCHER GL, 1990, PRINCIPLES PRACTICE, P1511

[3] DEVELOPMENT OF INVITRO RESISTANCE TO GLYCOPEPTIDE ANTIBIOTICS - ASSESSMENT IN STAPHYLOCOCCI OF DIFFERENT SPECIES [J].

BIAVASCO, F ;

GIOVANETTI, E ;

MONTANARI, MP ;

LUPIDI, R ;

VARALDO, PE .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 (01) :71-79

[4] Characterisation of coagulase-negative staphylococci isolated from blood infections: Incidence, susceptibility to glycopeptides, and molecular epidemiology [J].

Boisson, K ;

Thouverez, M ;

Talon, D ;

Bertrand, X .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2002, 21 (09) :660-665

[5] Emergence of teicoplanin-resistant coagulase-negative staphylococci [J].

Cercenado, E ;

GarciaLeoni, ME ;

Diaz, MD ;

SanchezCarrillo, C ;

Catalan, P ;

deQuiros, JCLB ;

Bouza, E .

JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (07) :1765-1768

[6] Methicillin-resistant Staphylococcus aureus and antimicrobial use in Belgian hospitals [J].

Crowcroft, NS ;

Ronveaux, O ;

Monnet, DL ;

Mertens, R .

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1999, 20 (01) :31-36

[7] Antimicrobial susceptibility of coagulase-negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptides [J].

Del'Alamo, L ;

Cereda, RF ;

Tosin, I ;

Miranda, EA ;

Sader, HS .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1999, 34 (03) :185-191

[8] Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals - A challenge to hospital leadership [J].

Goldmann, DA ;

Weinstein, RA ;

Wenzel, RP ;

Tablan, OC ;

Duma, RJ ;

Gaynes, RP ;

Schlosser, J ;

Martone, WJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (03) :234-240

[9] PERCENTAGES AND DISTRIBUTIONS OF TEICOPLANIN-RESISTANT AND VANCOMYCIN-RESISTANT STRAINS AMONG COAGULASE-NEGATIVE STAPHYLOCOCCI [J].

GOLDSTEIN, FW ;

COUTROT, A ;

SIEFFER, A ;

ACAR, JF .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (05) :899-900

[10]

GRANT AC, 1986, LANCET, V2, P1166